We have reported (Klein et al., 2009) that the blockade of the bradykinin B1 receptor (B1R) was associated to a curative antifibrotic effect in the unilateral ureteral obstruction (UUO) model as well as in a model of glomerulonephritis (Klein et al., 2010). Here, BDKRB1 is linked to Ureteral obstruction.